quick scan
WI-WE Progress
Progress: 78.75%   WWI-WE Version: 2
0 mandatory questions pending
26 questions total
21 questions answered
21 questions completed
5 questions pending
Popular WI-WE Tags

Mapping Wild Cards

Inspired by: interviews » Traditional European Medicine

version: 2 / updated: 2010-08-05
id: #940 / version id: #939
mode: VIEW

Originally submitted by: Sivert von Saldern
List of all contributors by versions (mouse over)
Last changed by: Sivert von Saldern
WI-WE status:
unpublished archived

Source of inspiration

Interviews

The source of the Wild Card is

Expert Interview on Health with Dr. Jo-hannes G. Mayer, Head of the re-search group “medical knowledge in monasteries” at Wuerzburg University, Germany.

Headline

(max. 9 words)

Traditional European Medicine

Description

(approx. 150 words)
Please describe the Wild Card (approx. 150 words)
Intense and highly funded research in the field of monastery medicine lead to the introduction of an officially approved medical treatment called “Traditional European Medicine” in all European member states. This medical treatment is based on the centuries-old knowledge in monasteries on the effective prophylactic and reactive treatment with natural active substances from medical plants. This “new” treatment is fully accepted by society and broadly recognised as an effective supplementary to conventional medicine.

Keywords

Health, Monasteries, Medical Plants, Pharmacy, Nutrition

Mini-description

(max. 250 characters)

Intense and highly funded research in the field of monastery medicine lead to the introduction of an officially approved medical treatment called “Traditional European Medicine” in all European member states.

Likelihood

Closest timeframe for at least 50% likelihood
Please use one of the following options:
now-2050

Features of life if the wild card manifests

Feature 1: business models and industrial environment
This wild card might have certain negative impacts, particularly on producers of mammals, classic pharmacies which only focus on selling synthetically produced pharmaceuticals, Internet pharmacies and last but not least pharma companies which refused to invest in research on medical plants. Another important aspects concerns the necessary reorientation of conventional doctors and pharmacies. In case this wild card emerged, the number of pharmacies producing their own pharmaceutical compounds and offering a broad range of consultation services might increase. This wild card could certainly result in the emergence of a new growth market “Traditional European Medicine”. There is great economic potential for both small and large enterprises, which define their role and business models at an early stage. New business models could for example include the purchase of medical plants sets for self-mixture at home, delivery services for convenience food based in traditional monastery recipes, nutritional consulting or wellness temples offering a broad variety of natural treatments. Further, there might be significant challenges for health insurances and specific contracts focussing on traditional European medicine.
Feature 6: health and quality of life
The emergence of this wild card could lead to an increased awareness towards ones own health and a growing self-prophylaxis, particularly with regards to common widespread diseases, cardiovascular diseases or different types of cancer. This is partly due to the significant value of healthy nutrition in medical knowlege in monasteries. Essential questions with regards to nutrition consist of „what do I eat, when do I eat and how do I eat“. Following these essencials in daily life, health of European societiies might enormously increase.

Type of event

Human planned (e.g. terrorist attack or funded scientific breakthrough)

Type of emergence

please select (if any) describe related trend or situation
A new development/situation
(e.g. a Romani state is established in central Europe; A message from an alien civilisation existing on a distant planet is received and understood, etc.

Historical parallels

Between the 8th and 13th century, It was the monasteries, which shaped the medical treatment in Europe. One can say that monasteries were the medieval hospital operators. Thus, in the course of time the nuns and monks gained profound knowledge on medical plants and their application fields and created manifold herb gardens. The theoretical base of this monastery medicine was mainly humoral pathology - the theory of four fluids. However, the European era of monastery medicine finally ended in the beginning of the 19th century due to secularisation, except in Slavic states and Italy, where the usage of European medical plants leads back to a continuous 2000-year lasting history.

Type of systems affected

Human-built Systems - E.g. organisations, processes, technologies, etc.

Classification

Desirable

Importance

please specify:
please select
Level 3: important for the European Union
Level 4: important for the whole world

Early indicators

(including weak signals)

There are several signals that either individually or in combination with others indicate the possibility of a prospective occurrence of this wild card scenario. First of all there are various signals related to the work of the research group “medical knowledge in monasteries” at the University of Wuerzburg. GlaxoSmithKline, the worlds second largest pharmaceutical company is supporting their work. Fur-ther, there has been an enormous increase of external requests at the research group lately. Lust but not least, the existence of the research group itself and the fact that this groups is financially supported are important weak signals. Another important signal might be a research group in Austria, which focuses on the exploration of some kind of traditional European medicine. They have already registered this research area at the UNESCO as an intellectual heritage and they try to es-tablish this area as an official medicine. Besides, this group is already conducting training seminars.

Latent phase

Obstacles for early indentification

information/communicational filters (media/editorial interests, language, reasoning)
cultural/religious filters (values, traditions, faith, spiritual beliefs)
institutional filters (rules, laws, regulations)
economic filters (business/market interests)
scientific filters (knowledge/technology access)
political filters (party or ideological interests)
social filters (class, status, education level)

Manifestation phase

Type of manifestation

Very uncertain

Aftermath phase

Important implications
Emergence of a new system (e.g. new technologies, new paradigms)

Relevance for Grand Challenges

where? please justify:
particularly relevant Europe world
Behavioural change
Diseases, health and well-being
Food security and diet

Relevance for thematic research areas

please justify:
particularly relevant
Health
Food, Agriculture and Fisheries, and Biotechnology

Pan-European strategies potentially helping to deal with the wild card

please justify:
particularly relevant
Improving researchers mobility and career development by, for example, realising a single labour market for researchers.
Developing and funding world-class research infrastructures
Strengthening research institutions and universities
Facilitating and promoting knowledge sharing and transfer
Increasing the efficiency and impact of public research through Joint Programming (i.e. combining national and pan-European research efforts) or the optimisation of research programmes and priorities, for example.
Fostering and facilitating coherent international cooperation in science and technology

 Features of a research-friendly ecology contributing to deal with the wild card

For further information about 'research-friendly strategies' click here

please justify:
particularly relevant
Overcoming sub-criticality and systemic failures
To be subcritical means that the effort in a particular field or subfield lacks resources, equipment or a sufficient number of researchers to achieve a desired goal
Strengthening the actors in the research-friendly ecology
(i.e. Research funding organisations, universities, businesses, Research and Technology Organisations, Researchers and Citizens)